Impact of brachytherapy on local recurrence rates after sublobar resection: Results from ACOSOG Z4032 (alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 32, Issue 23, 2014, Pages 2456-2462

  Fernando, Hiran C ^a   Landreneau, Rodney J ^b   Mandrekar, Sumithra J ^c   Nichols, Francis C ^c   Hillman, Shauna L ^c   Heron, Dwight E ^b   Meyers, Bryan F ^d   DiPetrillo, Thomas A ^e   Jones, David R ^f   Starnes, Sandra L ^g   Tan, Angelina D ^c   Daly, Benedict D T ^b   Putnam Jr , Joe B ^h  

^a BOSTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MAYO CLINIC   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e RHODE ISLAND HOSPITAL   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOLOGY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; LOCAL RECURRENCE; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SUBLOBAR RESECTION; SUBLOBAR RESECTION WITH BRACHYTHERAPY; TREATMENT OUTCOME; WEDGE RESECTION; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COHORT ANALYSIS; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 84905819846     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.4115     Document Type: Article

References (18)

1. Ginsberg RJ, Rubenstein LV: Randomized trial of lobectomy versus limited resection for T1NO non-small cell lung cancer. Ann Thorac Surg 60:615-623, 1995
2. Shennib H, Bogart J, Herndon JE, et al: Video-assisted wedge resection and local radiotherapy for peripheral lung cancer in high-risk patients: The Cancer and Leukemia Group B (CALGB) 9335, a phase II, multi-institutional cooperative group study. J Thorac Cardiovasc Surg 129:813-818, 2005 (Pubitemid 40487882)
3. d'Amato TA, Galloway M, Szydlowski G, et al: Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest 114:1112-1115, 1998 (Pubitemid 28495910)
4. Lee W, Daly BD, DiPetrillo TA, et al: Limited resection for non-small cell lung cancer: Observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 75:237-243, 2003
5. Fernando HC, Santos RS, Benfield JR, et al: Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 129:261-267, 2005 (Pubitemid 40169547)
6. Voynov G, Heron DE, Lin CJ, et al: Intraopeative (125)I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 4:278-285, 2005 (Pubitemid 41774586)
7. Sawabata N, Matsumura A, Ohota M, et al: Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg 74:1953-1957, 2002 (Pubitemid 35440861)
8. National Institutes of Health, National Cancer Institute: Common Terminology Criteria for Adverse Events (CTCAE) Version 3. http://ctep.cancer. gov/protocolDevelopment/electronic-applications/docs/ctcaev3.pdf
9. Fernando HC, Landreneau RJ, Mandrekar SJ, et al: Thirty and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer: Results from a multicenter phase III study. J Thorac Cardiovasc Surg 142:1143-1151, 2011
10. Warren WH, Faber LP: Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of recurrence. J Thorac Cardiovasc Surg 107:1087-1093, 1994
11. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737-751, 1993 (Pubitemid 23134304)
12. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
13. El-Sherif A, Fernando HC, Santos R, et al: Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol 14:2400-2405, 2007 (Pubitemid 47174921)
14. Schuchert MJ, Pettiford BL, Keeley S, et al: Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 84:926-933, 2007 (Pubitemid 47285059)
15. Timmerman RD, Park C, Kavanagh BD: The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2:S101-S112, 2007 (suppl 3)
16. Dupuy DE, DiPetrillo T, Gandhi S, et al: Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest 129:738-745, 2006
17. Grillis IS, Mangona VS, Welsh R, et al: Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 28:928-935, 2010
18. Timmerman R, Paulus R, Galvin J, et al: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070-1076, 2010